Hims & Hers first told investors about a regulatory review in July 2024, but Bloomberg's report adds new color on what ...

Hims & Hers Health (NYSE:HIMS) stock fell 4.1% in after-hours trading on Thursday following a Bloomberg report that revealed ...

A spokesperson for Hims did not immediately respond to a request for comment. The company previously said it was cooperating ...

Hims & Hers shares fall after a report says the FTC has investigated its cancellation policies and billing practices for over ...

For more than a year, the Federal Trade Commission has been investigating Hims & Hers Health Inc.’s business practices, including whether it has made it too hard for customers to cancel subscriptions, ...

After Bloomberg reported, citing people familiar with the probe, that the Federal Trade Commission has been investigating ...

Telehealth company Hims & Hers Health’s (HIMS) business practices have been under investigation by the U.S. Federal Trade Commission (FTC) for over a year, Bloomberg reported. Following the news, HIMS ...

The US health sector is bustling with activity. Key developments include an FTC investigation into Hims & Hers' practices, ...

Allen Lutz has given his Buy rating due to a combination of factors including the strong brand equity of Hims & Hers Health and the strategic appointment of a new board member with significant ...

Investors who lost money in Hims & Hers (NYSE: HIMS) are being urged to actively participate in a securities class action lawsuit. The lawsuit alleges that Hims made misleading statements about its ...

Berkshire Hathaway invests in UnitedHealth; FTC investigates Hims & Hers for advertising practices; U.S. health department ...